IL1A and COVID-19: Furthermore, COVID-19–related cytokine storm shares similarities with other autoinflammatory conditions characterized by hyperinflammation such as adult onset Still’s disease and macrophage activation syndrome in which IL-1 pathway is a major target for treatment [33,34].